Luquain Alexandra, Arbez-Gindre Francine, Bedgedjian Isabelle, Felix Sophie, Harimenshi Jean-Marie, Mihai Ionela-Marcela, Monnien Franck, Singeorzan Cristina, Valmary-Degano Séverine
Service d'anatomie et cytologie pathologiques et de biologie cellulaire et moléculaire, CHRU, 2, boulevard Fleming, 25000 Besançon, France.
Service d'anatomie et cytologie pathologiques et de biologie cellulaire et moléculaire, CHRU, 2, boulevard Fleming, 25000 Besançon, France; EA 3181, FED 4234, université de Franche-Comté, Les Hauts du Chazal, 19, rue Ambroise-Paré, 25000 Besançon, France.
Ann Pathol. 2016 Aug;36(4):268-74. doi: 10.1016/j.annpat.2016.06.004. Epub 2016 Jul 26.
Before molecular analysis is performed, morphological control with an estimation of the tumour cell percentage (%TC) could have a major impact on mutation detection. Accreditation according to NF EN ISO 15189 commands an authorization through evaluation of skills. The objective of this work was to validate the empowerment of pathologists to estimate %TC in tissue sample prior to molecular analysis. The accreditation technical guidance methods in Medical biology and histopathology were taken as references. %TC was the ratio of tumour cell nuclei on all nuclei within the area selected for the DNA extraction. External evaluations quality scores were used for accuracy. In order to assess the intermediate precision, 35 %TC estimation were performed 15 days apart in 4 samples (biopsies, transparietal biopsies or surgical specimen, either fixed or frozen) by 7 pathologists. Three other cases with interference (inflammation, mucus, necrosis) were evaluated. A result was satisfactory if %TC were within ±20 % of expected percentage obtained by the average of 35 estimates. The performances were satisfactory since no estimate was made more than 20 % of the expected percentage. Low interpathologists reproducibility has been reported in the literature and can have a consequence on molecular analysis in samples with low %TC, where the value reach the analytical sensitivity thresholds of molecular techniques. The current report is an example of a step of the accreditation process, which is a challenge for pathologists' activity in the future.
在进行分子分析之前,通过估计肿瘤细胞百分比(%TC)进行形态学控制可能对突变检测产生重大影响。根据NF EN ISO 15189进行的认可要求通过技能评估获得授权。这项工作的目的是验证病理学家在分子分析之前估计组织样本中%TC的能力。以医学生物学和组织病理学中的认可技术指导方法为参考。%TC是所选用于DNA提取区域内所有细胞核中肿瘤细胞核的比例。使用外部评估质量分数来评估准确性。为了评估中间精密度,7名病理学家在4个样本(活检、经皮活检或手术标本,固定或冷冻)中每隔15天进行35次%TC估计。对另外3例有干扰(炎症、黏液、坏死)的病例进行了评估。如果%TC在35次估计平均值所得预期百分比的±20%范围内,则结果令人满意。由于没有估计值超过预期百分比的20%,因此性能令人满意。文献报道病理学家之间的再现性较低,这可能会对%TC较低的样本中的分子分析产生影响,因为该值达到了分子技术的分析灵敏度阈值。本报告是认可过程中一个步骤的示例,这对未来病理学家的工作是一项挑战。